Armata Pharmaceuticals, Inc. (ARMP)
NYSEAMERICAN: ARMP · Real-Time Price · USD
2.190
+0.100 (4.78%)
Nov 21, 2024, 9:30 AM EST - Market open

Armata Pharmaceuticals Revenue

Armata Pharmaceuticals had revenue of $2.97M in the quarter ending September 30, 2024, with 142.69% growth. This brings the company's revenue in the last twelve months to $5.47M, up 34.92% year-over-year. In the year 2023, Armata Pharmaceuticals had annual revenue of $4.53M, down -17.77%.

Revenue (ttm)
$5.47M
Revenue Growth
+34.92%
P/S Ratio
13.82
Revenue / Employee
$82,833
Employees
66
Market Cap
79.24M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 20234.53M-979.00K-17.77%
Dec 31, 20225.51M1.03M23.11%
Dec 31, 20214.47M3.65M443.62%
Dec 31, 2020823.00K--
Dec 31, 2019---
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Inotiv 501.06M
CytomX Therapeutics 126.62M
MDxHealth 84.71M
BioAtla 11.00M
BeyondSpring 1.88M
Vistagen Therapeutics 876.00K
Ovid Therapeutics 631.70K
Revenue Rankings